-
We Are Now Open On Saturdays
-
20 Old Brompton Road, South Kensington, London SW7 3DL
We Are Now Open On Saturdays
20 Old Brompton Road, South Kensington, London SW7 3DL
We have alphabetically arranged a list of every blood test we offer in our private clinic and the prices you will be required to pay for your results. The time taken for each result to be ready is also attached.
We would love you to know that before the blood tests, you will have to book an appointment to meet with our doctor for about 15 minutes for the sample collection. For this consultation, you will have to pay a token of £65, which will cover the sample collection, interpretation and explanation of the results to you by our GP.
Here is the alphabetical list of all our blood tests:
| CODE | TEST NAME | TAT | Price |
|---|---|---|---|
| 10A | Allergy Profile 10 (Insects) | 2 days | 212 |
| 10AL | Allergy – 10 x Single Individual Allergens | 2 days | 350 |
| 10RF | HLA DQ Alpha Antigens | 2 weeks | 220 |
| 11A | Allergy Profile 11 (Combined Shellfish/Finfish) | 2 days | 239 |
| 11RF | HLA DQ Beta Antigens | 2 weeks | 220 |
| 12A | Allergy Profile 12 (Milk & Milk Proteins) | 2 days | 263 |
| 13A | Allergy Profile 13 (Stone fruit/Rosaceae family) | 2 days | 263 |
| 14RF | HLA A, B, C | 2 weeks | 337 |
| 16RF | NK Assay Panel + Intralipids | 1 week | 708 |
| 17OH | 17 Hydroxyprogesterone | 5 days | 137 |
| 17RF | KIR (Killer-like Immunoglobulin-like Receptors) Genotyping | 2-3 weeks | 446 |
| 1A | Allergy Profile 1 (Food & Inhalants) | 2 days | 665 |
| 1TH2 | TH1/TH2 Cytokine Profile | Send Mon-Thurs only | 430 |
| 20RF | TH1/TH2 Intracellular Cytokine Ratios with IVIG, Prednisolone | 1 week | 934 |
| 21RF | TH1/TH2 Intracellular Cytokine Ratios with IVIG | 1 week | 748 |
| 22RF | TH1/TH2 Intracellular Cytokine Ratios with Prednisolone | 1 week | 748 |
| 25RF | T Regulatory Cells | 3 days | 691 |
| 26RF | HLA-C | 2 weeks | 220 |
| 2A | Allergy Profile 2 (UK Aero Allergen) | 2 days | 366 |
| 2C19 | Cytochrome P450 2C19 | 10 days | 543 |
| 3A | Allergy Profile 3 (Food) | 2 days | 332 |
| 3RF | Reproductive Immunophenotype Panel | 1 week | 482 |
| 4A | Allergy Profile 4 (Nuts & Seeds) | 2 days | 470 |
| 4RF | NK Assay/Cytotoxicity Panel | 1 week | 569 |
| 5A | Allergy Profile 5 (Children’s Panel) | 2 days | 332 |
| 5AL | Allergy – 5 x Single Individual Allergens | 2 days | 181 |
| 5FU | Dihydropyrimidine Dehydrogenase deficiency screening (Fluoropyrimidine Toxicity) | 1-2 weeks | 430 |
| 5NT | 5’ Nucleotidase | 5 days | 98 |
| 5RF | NK Assay Follow-Up Panel | 1 week | 482 |
| 69C | NK (CD69) and NK Cytotoxicity | Send Mon-Thurs only | 900 |
| 69CI | NK Cytotoxicity with suppression with steroid, IVIg and intralipin, and NK (CD69) cell assay | Send Mon-Thurs only | 1058 |
| 6A | Allergy Profile 6 (Shellfish) | 2 days | 298 |
| 6RF | TH1/TH2 Cytokine Ratio | 1 week | 446 |
| 7A | Allergy Profile 7 (Finfish) | 2 days | 298 |
| 8A | Allergy Profile 8 (Cereal – singles) | 2 days | 174 |
| 8RF | Leucocyte Antibody Detection Panel FEMALE | 1 week | 271 |
| 9A | Allergy Profile 9 (Antibiotics) | 2 days | 136 |
| 9RF | HLA DR Antigens | 2 weeks | 271 |
| A1AF | Alpha-1-Antitrypsin (Stool) | 10 days | 106 |
| A1AT | Alpha-1-Antitrypsin (Serum) | 1 day | 139 |
| A1MG | Alpha-1-Microglobulin | 10 days | 100 |
| A2MG | Alpha-2-Macroglobulins | 5 days | 133 |
| AA2R | Anti-Phospholipase A2 Receptor | 6 weeks | 121 |
| AAA | Anti-Actin Antibodies | 5 days | 100 |
| AASC | Atypical Antibody Screen (handwritten tube label) | 2 days | 67 |
| ABGA | Anti-Basal Ganglia Antibodies | 3 weeks | 503 |
| ABO | Blood Group † | 2 days | 74 |
| ACAB | Cardiolipin Antibodies (IgG+IgM) | 2 days | 94 |
| ACE | Angiotensin Converting Enzyme | 1 day | 103 |
| ACRA | Acetylcholine Receptor Autoantibodies | 5 days | 257 |
| ACTB | Acetone – Blood | 6 weeks | 133 |
| ACTU | Acetone – Urine | 5 days | 133 |
| ACTX | Adrenal Cortex Antibodies | 2 days | 75 |
| AD | Adenosine Deaminase | 3 weeks | 345 |
| ADIP | Adiponectin | 2 weeks | 274 |
| ADV | Adenovirus by PCR | 7 days | 323 |
| AFAT | Amoebic (E. histolytica) Antibodies | 1 week | 62 |
| AFP | Alpha-Fetoprotein | 1 day | 68 |
| AGAB | Gliadin Antibodies (IgG) (deamidated) (Venous) | 2 days | 113 |
| AGBM | Glomerular Basement Membrane Abs | 2 days | 88 |
| AHSC | Acute Viral Hepatitis Screen | 1 day | 211 |
| AHT | Hyaluronic Acid | 1 week | 84 |
| ALB | Albumin | 1 day | 35 |
| ALCA | Anti-Liver Cytosol Antibodies | 5 days | 91 |
| ALCO | Alcohol (Medical) | 1 day | 97 |
| ALCP | Alcohol Profile 2 | 5-7 days | 311 |
| ALDN | Aldosterone | 5 days | 158 |
| ALDO | Aldolase | 5 days | 71 |
| ALEC | Atopic Dermatitis/Eczema Profile (14 allergens) | 2 days | 380 |
| ALEX | ALEX² Allergy Test (Venous) | 3-4 days | 380 |
| ALLE | Allergy – Individual Allergens | 2 days | 48 |
| ALP | Alkaline Phosphatase | 1 day | 35 |
| ALRN | Allergic Rhinitis/Asthma Profile | 2 days | 355 |
| ALRP | Leukaemia (Rapid Acute) DNA and RNA NGS Panel . Requires patient informed consent | 3 days | 824 |
| ALT | ALT (Alanine Aminotransferase) (SGPT) | 1 day | 35 |
| ALUM | Aluminium (Blood) | 7 days | 91 |
| ALUU | Aluminium (Urine) | 1-2 weeks | 123 |
| AMAG | Amoebic (E. histolytica) PCR | 2 days | 63 |
| AMEN | Amenorrhoea Profile (Venous) | 1 day | 172 |
| AMH | Antimullerian Hormone (AMH) (Venous) | 1 day | 150 |
| AMIK | Amikacin Level (State dose) | 1 day | 139 |
| AMIT | Mitochondrial Antibodies | 3 days | 62 |
| AMOG | Anti-MOG [Myelin Oligodendrocyte Glycoprotein] Antibodies | 3 weeks | 147 |
| AMPB | Amphetamines – Blood | 5 days | 104 |
| AMTR | Amitriptyline | 5 days | 132 |
| AMY | Amylase (Venous) | 1 day | 59 |
| AMYI | Amylase lsoenzymes | 5 days | 221 |
| ANAB | Anti-Nuclear Antibodies (titre & pattern) | 2 days | 63 |
| ANAE | Anaemia Profile | 2 days | 200 |
| ANCA | ANCA (Anti-Neutrophil Cytoplasmic Abs) | 2 days | 133 |
| ANDG | Androstanediol Glucuronide | 3 weeks | 167 |
| ANDP | Andropause Profile | 1 day | 212 |
| ANDR | Androstenedione | 5 days | 108 |
| ANTE | Antenatal Profile | 3 days | 676 |
| ANTI | Antimony (Urine) | 10 days | 121 |
| AP | Alcohol Profile | 5-7 days | 230 |
| APEG | Apolipoprotein E genotype – E2/E3/E4 | 2 weeks | 270 |
| APIE | Alkaline Phosphatase lsoenzymes | 5 days | 139 |
| APOA | Apolipoprotein A1 (Venous) | 3 days | 87 |
| APOB | Apolipoprotein B (Venous) | 3 days | 87 |
| APOC | Apolipoprotein C | 3 months | 104 |
| APOE | Apolipoprotein E (12 hours fasting) | 5 days | 106 |
| APS | Atypical Pneumonia Screen | 3 days | 160 |
| APS | Pneumonia (Atypical) Screen | 3 days | 160 |
| APT | Acid Phosphatase – Total | 5 days | 60 |
| APT | Total Acid Phosphatase | 5 days | 60 |
| AQUA | Aquaporin 4 Antibodies (Neuromyelitis Optica) | 2 weeks | 317 |
| ARBO | Arbovirus Antibodies/Abs | 3 weeks | 221 |
| ARS | Arsenic (Blood) | 5 days | 96 |
| ARSE | Arsenic (Urine) | 5 days | 96 |
| ARYL | Arylsulphatase A | 8 weeks | 374 |
| ASA | Anti-Sulfatide Antibodies | 5 weeks | 295 |
| ASAB | Sperm Antibodies (Serum) | 5 days | 159 |
| ASC | Ascariasis Serology | 5 days | 100 |
| ASCA | Saccharomyces Cerevisiae Antibodies | 2 weeks | 159 |
| ASLT | Anti-Streptolysin Titre/ASOT | 2 days | 68 |
| ASMO | Smooth Muscle Antibodies | 2 days | 62 |
| ASPP | Aspergillus Precipitins | 5 days | 147 |
| AST | Aspartate Transaminase (AST) (SGOT) | 1 day | 35 |
| ASTT | Anti-Staphylolysin Titre (SGOT) | 3 days | 66 |
| AUTO | Autoantibody Profile I | 2 days | 174 |
| AVIA | Avian Precipitins (11 Species) | 5 days | 424 |
| B12 | Vitamin B12 (Active) (Venous) | 1 day | 81 |
| B12F | Vitamin B12 (Active)/Red Cell Folate | 2 days | 128 |
| B2GP | Beta 2 Glycoprotein 1 Abs | 2 days | 142 |
| B2MG | Beta 2 Microglobulin (Serum) | 2 days | 111 |
| B51 | Behcet’s Disease – HLA Tissue Typing B*51 | 10 days | 276 |
| B51 | HLA Tissue Typing B*51 (Behcet’s Disease) | 10 days | 276 |
| BCRD | BCR-ABL Diagnostic Assay | 2 weeks | 451 |
| BCRQ | BCR/ABL Quantitative – fusion gene sizes p190 + p210 | 10 days | 422 |
| BCUL | Blood Culture# | 6 days + | 114 |
| BGLU | Beta-Glucuronidase (Sly Disease) | 8 weeks | 317 |
| BILE | Bile Acids – Serum | 1 day | 76 |
| BILH | Bilharzia (Schistosome) Antibody Screen | 10 days | 133 |
| BILH | Schistosome (Bilharzia) Antibodies | 10 days | 133 |
| BILI | Bilirubin (Total) | 1 day | 35 |
| BILS | Total Bile Acid/Bile Salts | 1 week | 97 |
| BIOS | Biotin | 5 days | 177 |
| BIOS | Vitamin B7 (Biotin) | 5 days | 177 |
| BISM | Bismuth | 5 days | 185 |
| BKPV | BK Polyoma Virus by PCR | 5 days | 271 |
| BNP | BNP (NT-pro BNP) | 1 day | 108 |
| BON2 | Bone Screen (Bloods only) | 1 day | 148 |
| BONE | Bone Screen | 1 day | 64 |
| BORC | Borrelia Confirmation (Immunoblot) | 10 days | 403 |
| BORM | Borrelia Antibodies (Lyme Disease) IgM | 2 days | 84 |
| BORM | Lyme Disease (Borrelia Abs) IgM | 2 days | 84 |
| BORR | Borrelia Antibodies (Lyme Disease) IgG, IgM | 2 days | 108 |
| BORR | Lyme Disease (Borrelia Abs) IgG, IgM | 2 days | 108 |
| BPCR | Blood PCR for Chromosome 13, 18, 21 and sex chromosomes | 5 days | 307 |
| BROM | Bromide | 3 days | 170 |
| BRUC | Brucella Serology | 2-3 weeks | 113 |
| BUN | BUN (Blood Urea Nitrogen) (Calculated) | 1 day | 38 |
| BUTA | 2-Butanone GC | 7 days | 177 |
| C125 | CA 125 (Venous) | 1 day | 146 |
| C153 | CA 15-3 | 1 day | 146 |
| C199 | CA 19-9 | 1 day | 146 |
| C1EI | C1 Esterase Inhibitor | 5 days | 106 |
| C1Q | Complement C1q | 5 days | 87 |
| C2 | Complement C2 | 10 days | 198 |
| C3 | C3 Complement | 1 day | 63 |
| C3 | Complement C3 | 1 day | 63 |
| C4 | C4 Complement | 1 day | 63 |
| C4 | Complement C4 | 1 day | 63 |
| C5A | Complement C5 | 2 weeks | 198 |
| C724 | CA 72-4 | 5 days | 156 |
| CA | Calcium (Venous) | 1 day | 35 |
| CA2A | Colloid Antigen-2 Antibodies | 2 weeks | 142 |
| CA50 | CA 50 | 5 days | 181 |
| CACR | Calcium/Creatinine Ratio | 1 day | 66 |
| CADM | Cadmium (Blood) | 5 days | 96 |
| CALD | Calcium + Vitamin D (Venous) | 1 day | 122 |
| CALP | Calprotectin | 5 days | 111 |
| CALP | Calprotectin (Self-collect) | 5 days | 111 |
| CANA | Candida Antibodies | 5 days | 137 |
| CANC | Candida (Culture for ID Only) | 2-4 days | 93 |
| CAND | Candida (Culture for ID + Sensitivities) | 2-4 days | 93 |
| CANN | Cannabinoids (Urine) Screen | 1 day | 63 |
| CANS | Candida auris Screen | 2-4 days | 118 |
| CARB | Carbamazepine (Tegretol) | 1 day | 75 |
| CARB | Tegretol (Carbamazepine) | 1 day | 75 |
| CARO | Beta Carotene | 5 days | 159 |
| CARO | Carotenes | 5 days | 159 |
| CAT | Cat Scratch Fever (Bartonella IgG) | 5 days | 239 |
| CATF | Fluid Cytology | 3 days | 186 |
| CBHB | Carboxyhaemoglobin | 1 week | 96 |
| CCAB | Voltage Gated Calcium Channel Antibodies | 3 weeks | 309 |
| CCP | Anti-CCP Antibodies | 2 days | 62 |
| CCP | CCP Antibodies (RF) | 2 days | 62 |
| CD16 | CD16 | 1 day | 142 |
| CD19 | CD19 B Cells | 1 day | 142 |
| CD20 | CD20 | 2 days | 155 |
| CD25 | CD25 | 2 days | 104 |
| CD56 | CD56 | 1 day | 100 |
| CD57 | CD57 | 1 day | 137 |
| CD69 | NK (CD69) Cell Assay | Send Mon-Thurs only | 324 |
| CDG | Carbohydrate Deficient Glycoprotein | 2 weeks | 337 |
| CDT | Carbohydrate Deficient Transferrin (CDT) (Venous) | 3 days | 185 |
| CEA | Carcino Embryonic Antigen | 1 day | 91 |
| CERS | Swab (Cervical) | 2-4 days | 93 |
| CERU | Caeruloplasmin | 1 day | 66 |
| CFS | Cystic Fibrosis (139 common variants) – reflex to Poly T when required | 5-7 days | 378 |
| CGA | Chromogranin A | 1 week | 188 |
| CGEN | Hepatitis C Genotype | 5 days | 658 |
| CGH | Postnatal SNP Array CGH | 10 days | 945 |
| CHGA | Chagas Disease Serology (S.American Trypanosomiasis) T. Cruzi | 10 days | 173 |
| CHGA | Trypanosome (Chagas) Antibodies | 10 days | 173 |
| CHIK | Chikungunya Virus Abs | 10 days | 221 |
| CHLO | Anafranil (Clomipramine) | 7 days | 139 |
| CHLO | Clomipramine (Anafranil) | 7 days | 139 |
| CHO | Cholesterol | 1 day | 32 |
| CHPS | Cholinesterase (Serum/Pseudo) | 1 day | 64 |
| CHRO | Chromium (Blood) | 5 days | 84 |
| CITR | Citrate (Blood) | 5 days | 103 |
| CJAB | Campylobacter Jejuni Antibodies | 5 days | 93 |
| CKIE | CK Isoenzymes | 5 days | 139 |
| CKMB | CK (MB Fraction) | 1 day | 58 |
| CKNA | Creatine Kinase (CK, CPK) | 1 day | 41 |
| CL | Chloride | 1 day | 29 |
| CLOB | Clobazam | 5 days | 139 |
| CLON | Clonazepam | 7 days | 125 |
| CLOS | Clostridium Difficile Toxin by PCR | 2 days | 118 |
| CLOT | Coagulation Profile 2 | 1 day | 125 |
| CLPF | Coagulation Profile 1 | 1 day | 96 |
| CMAV | Cytomegalovirus Avidity | 10 days | 150 |
| CMV | Cytomegalovirus (IgG/IgM) Antibodies | 1 day | 97 |
| CMVM | CMV IgM Antibodies | 1 day | 156 |
| CMVP | Cytomegalovirus DNA (PCR) | 5 days | 300 |
| CMVR | Cytomegalovirus Resistance | 21 days | 757 |
| CMVU | Cytomegalovirus (PCR) Urine | 5 days | 300 |
| COB | Cobalt (Blood) | 5 days | 96 |
| COBA | Cobalt (Urine) | 5 days | 96 |
| COMP | C3/C4 Complement | 1 day | 104 |
| COOM | Coombs (Direct Antiglobulin Test) | 2 days | 40 |
| COPP | Copper (Serum) | 5 days | 71 |
| CORT | Cortisol (Venous) | 1 day | 66 |
| COT | Cotinine (Serum) | 4 days | 110 |
| COTT | Cotinine (Urine) | 2 days | 83 |
| CPEP | C Peptide | 3 days | 154 |
| CPP | Chest Pain Profile | STAT | 158 |
| CPSA | Complex PSA (Prostate Specific Ag) | 3 days | 91 |
| CQ10 | Coenzyme Q10 | 2 weeks | 188 |
| CRCL | Creatinine Clearance | 1 day | 63 |
| CREA | Creatinine (including eGFR) (Venous) | 1 day | 35 |
| CRP | C Reactive Protein (Venous) | 1 day | 62 |
| CRPA | Cryptosporidium Detection by PCR | 2 days | 93 |
| CURT | Histamine Releasing Urticaria Test | 3 weeks | 196 |
| CURT | Urticaria Test (Histamine Releasing) | 3 weeks | 196 |
| CY21 | Cyfra 21-1 | 4 days | 228 |
| CYCC | Cystatin C | 5 days | 120 |
| CYCL | Cyclosporin | 1 day | 155 |
| D3 | 1,25 Vitamin D | 5-8 days | 171 |
| D3 | Vitamin D (1, 25 Dihydroxy) | 5-8 days | 171 |
| DBIL | Bilirubin (Direct) | 1 day | 35 |
| DDIT | D-Dimers (Fibrinogen Degradation Products) | 1 day | 83 |
| DENG | Dengue Virus Serology | 5 days | 142 |
| DEOX | 11 Deoxycorticosterone | 10 days | 147 |
| DERM | Fungal investigations (superficial/dermatophyte PCR test) | 3-7 days | 93 |
| DHEA | DHEA Sulphate (Venous) | 1 day | 96 |
| DHEX | DHEA | 7-10 days | 163 |
| DHT | Dihydrotestosterone | 7 days | 155 |
| DIA2 | Diabetic Profile 2 | 2 days | 142 |
| DIAB | Diabetic Profile 1 | 1 day | 74 |
| DIAM | Diamine Oxidase Activity | 2 weeks | 113 |
| DIAZ | Diazepam (Valium) | 7 days | 125 |
| DIAZ | Valium (Diazepam) | 7 days | 125 |
| DIGO | Digoxin | 1 day | 103 |
| DIPH | Diphtheria Antibodies | 5 days | 100 |
| DL1 | DL1 Biochemistry Profile | 1 day | 57 |
| DL10 | Cardiovascular Risk Profile 1 | 3 days | 416 |
| DL10 | Screening Profile 10 – Cardiovascular Risk 1 | 3 days | 416 |
| DL11 | Cardiovascular Risk Profile 2 | 3 days | 502 |
| DL11 | Screening Profile 11 – Cardiovascular Risk 2 | 3 days | 502 |
| DL1L | DL1L Biochemistry Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 63 |
| DL2 | DL2 Biochemistry (24 Parameters) & Haematology Profile | 1 day | 74 |
| DL3 | DL3 Haematology Profile | 1 day | 36 |
| DL4 | DL4 Biochemistry (16 Parameters) & Haematology Profile | 1 day | 68 |
| DL5L | Screening Profile 5 – Haematology/Biochemistry (Postal) | 1 day | 202 |
| DL6 | DL6 General Well Person Profile | 1 day | 149 |
| DL7 | DL7 Well Man Profile | 1 day | 183 |
| DL7L | DL7L Well Man Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 189 |
| DL8 | DL8 Well Person Profile | 1 day | 183 |
| DL8L | DL8L Well Person Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 189 |
| DL9F | Screening Profile 9F – Senior Female | 2 days | 613 |
| DL9M | Screening Profile 9M – Senior Male | 2 days | 641 |
| DMD1 | Becker/Duchenne Muscular Dystrophy – deletions/duplications | 10 days | 827 |
| DMD1 | Duchenne Muscular Dystrophy – deletions/duplications only | 10 days | 827 |
| DNA | Nucleic Acid Antigen Antibodies | 2 days | 91 |
| DNAA | DNA (Double Stranded) Antibodies IgG | 2 days | 75 |
| DNAC | Zygosity Testing – comparative DNA profile | 5 days | 765 |
| DNAF | DNA Identity Profile – 15 STR markers | 10 days | 458 |
| DNAF | Identity Profile (DNA) – 15 STR markers | 10 days | 458 |
| DNAS | DNA (Single Stranded) Antibodies | 5 days | 84 |
| DOXE | Doxepin Level (Sinequan) | 10 days | 139 |
| DOXE | Sinequan (Doxepin) | 10 days | 139 |
| DPCR | Dengue Fever PCR | 2 weeks | 328 |
| DPD | Deoxypyridinoline (DPD) – Urine | 4 days | 123 |
| DPRO | Propoxyphene | 5 days | 132 |
| DRB1 | HLA Tissue Typing DRB1/3/4/5 | 10 days | 276 |
| DRNA | Hepatitis Delta RNA | 5 days | 329 |
| DUST | Phencyclidine (PCP) | 5 days | 94 |
| DVT1 | DVT/Pre-travel Screen | 5 days | 329 |
| DVT1 | Pre-Travel Screen (DVT) | 5 days | 329 |
| E1 | Oestrone | 4 days | 123 |
| E3 | Oestriol (Estriol) | 4 days | 123 |
| EARS | Swab (Ear) | 2-4 days (Culture) 8-9 days (Fungal) – same swab | 93 |
| EBVA | Epstein-Barr Virus Antibodies IgG/IgM | 2 days | 182 |
| EBVQ | Epstein-Barr Virus PCR | 5 days | 177 |
| ECP | Eosinophil Cationic Protein | 7 days | 151 |
| EFAR | Essential Fatty Acid Profile (Red Cell) | 10 days | 223 |
| EFAT | Echinococcus (Hydatid) Antibodies | 5 days | 82 |
| EHEP | Hepatitis E RNA (PCR) | 2 weeks | 263 |
| EHRL | Ehrlichiosis Antibodies | 10 days | 137 |
| ELAS | Elastase (RF) | 5 days | 128 |
| ELAS | Elastase (Self-collect) | 5 days | 128 |
| ELEC | Electrolytes | 1 day | 41 |
| ELF | ELF/Enhanced Liver Fibrosis | 5 days | 234 |
| ELF | Liver Fibrosis (Enhanced Liver Fibrosis ELF) | 5 days | 234 |
| EMA | Eosin-5 Maleimide Dye binding test for Hereditary spherocytosis (EMA)* | 2 days | 190 |
| ENA | Extractable Nuclear Antibodies (nRNP, Sm, Ro, La, Jo1, Scl70) CENP-B | 2 days | 87 |
| ENDO | Autoantibody Profile II | 3 days | 165 |
| ENDT | Ziwig Endotest® | 25 days | 977 |
| EORD | Enteric Organism Rapid Detection (RF) | 2 days | 257 |
| EORD | Enteric Organism Rapid Detection (Self-collect) | 2 days | 257 |
| EORD | Gastrointestinal Pathogen Profile by PCR (Self-collect) | 2 days | 257 |
| ERY | Erythropoietin | 4 days | 105 |
| ESR | ESR | 1 day | 38 |
| ETG | Urine EtG (Ethyl glucuronide) | 1 week | 129 |
| ETHO | Ethosuximide | 7 days | 88 |
| EYES | Swab (Eye) | 2-4 days | 93 |
| F8IA | Factor VIII Inhibiting Antibody | 2 weeks | 147 |
| F9IA | Factor IX Inhibiting Antibody | 2 weeks | 147 |
| FACH | Complement Factor H | 3 weeks | 194 |
| FARM | Farmers Lung Precipitins | 5 days | 131 |
| FASC | Fasciola Hepatica Antibodies (Liver Fluke) | 2 weeks | 166 |
| FBC | Full Blood Count | 1 day | 56 |
| FCG | FAST CT/GC – Urine | 1 day | 124 |
| FE | Iron (TIBC included) (Venous) | 1 day | 38 |
| FERR | Ferritin (Venous) | 1 day | 96 |
| FFAT | Faecal Fat (3 day) | 5 days | 150 |
| FIB | Fibrinogen | 1 day | 51 |
| FIBT | Fibrotest (Liver Fibrosis) | 2 weeks | 329 |
| FIBT | Liver Fibrosis Fibrotest | 2 weeks | 329 |
| FIFA | Filaria (Lymphatic and Non-Lymphatic) Antibodies | 10 days | 132 |
| FILM | Blood Film Examination | 1 day | 41 |
| FIP | Female Hormone Profile (Venous) | 1 day | 172 |
| FIRI | Fasting Insulin Resistance Index (FIRI) | 1 day | 98 |
| FK5 | FK506 (Tacrolimus/Prograf) | 1-2 days | 160 |
| FK5 | Tacrolimus/Prograf (FK506) | 1-2 days | 160 |
| FLAC | Faecal Lactoferrin | 5 days | 100 |
| FLEA | Insect/Worm/Ova/Cysts | 5 days | 120 |
| FLEC | Flecainide (Tambocor) | 5 days | 147 |
| FLT3 | FLT3-ITD and FLT3-TKD screening assay | 24 hours | 524 |
| FLU2 | Synovial Fluid (for microscopy, crystals and culture) | 14 days | 156 |
| FLU4 | Respiratory PCR Panel (COVID-19, Flu A/B and RSV) (PCR) | 2 days | 269 |
| FLU4 | Respiratory PCR Panel (COVID-19, Flu A/B and RSV) (Self-collect) | 2 days | 269 |
| FLUD | Fluid Culture | 2-7 days | 132 |
| FLUP | Pleural Fluid for Culture | 7 days | 132 |
| FOLA | Folate (Serum) | 1 day | 60 |
| FOLA | Vitamin B9 (Folic acid) – Serum | 1 day | 60 |
| FOS | Trimethylaminuria (Fish Odour Syndrome) | 6 weeks | 447 |
| FPOR | Porphyrin (Stool) | 3 weeks | 151 |
| FRCG | FAST CT/GC – Rectal PCR Swab | 1 day | 124 |
| FRUC | Fructosamine | 1 day | 55 |
| FSH | FSH (Venous) | 1 day | 63 |
| FSSC | FAST Screen SHORT with Urine | 1 day | 173 |
| FSSS | FAST Screen SHORT with Swab | 1 day | 173 |
| FSWS | FAST Screen with Swab | 1 day | 319 |
| FT3 | Free T3 (Venous) | 1 day | 63 |
| FT4 | Free T4 (Venous) | 1 day | 63 |
| FTCG | FAST CT/GC – Throat PCR Swab | 1 day | 124 |
| FTES | Testosterone (Free) (Venous) | 3 days | 129 |
| FTMS | First Trimester Maternal Screen (PAPP-A/Free Beta-hCG) | 1 day | 104 |
| FUN | Fungal investigations (non-superficial extended culture) | 3-21 days | 93 |
| FUNC | Vitamin B (Functional) | 5 days | 170 |
| FUSC | FAST Screen with Urine | 1 day | 319 |
| FVWF | Von Willebrand Profile | 5 days | 263 |
| FX2 | Factor II Prothrombin – G20210A Variant | 5 days | 248 |
| FX5 | Factor V Leiden – G1691A Variant | 5 days | 248 |
| G6PD | G6PD | 4 days | 116 |
| GABA | Gabapentin | 5 days | 117 |
| GACA | Ganglionic Acetylcholine Receptor Antibodies | 9 weeks | 136 |
| GAD | Glutamic Acid Decarboxylase Antibodies (GAD 65) | 5 days | 185 |
| GAL1 | Galactose-1-Phosphate Uridyltransferase | 2 weeks | 296 |
| GALA | Galactosidase – Alpha* | 6 weeks | 360 |
| GANG | Ganglioside GM1, GD1B, GQ1B Abs | 5 days | 279 |
| GASP | Gastric Parietal Autoantibodies | 2 days | 62 |
| GBSX | Group B Strep – Vaginal and Rectal (Self-collect) | 3-5 days | 63 |
| GBSX | Group B Strep – Vaginal and Rectal (STM) | 3-5 days | 63 |
| GENT | Gentamicin Assay | 1 day | 132 |
| GGT | Gamma GT | 1 day | 32 |
| GH | Growth Hormone (Fasting) | 1 day | 71 |
| GHB | HbA1c (Venous) | 1 day | 63 |
| GLOB | Globulin (Calculated) | 1 day | 38 |
| GLUG | Glucagon | 10 days | 257 |
| GLUT | Gluten Sensitivity Profile | 10 days | 424 |
| GRIM | Granulocyte Immunology | 2 weeks | 515 |
| GRP | Azoospermia – karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Congenital Absence of Vas Deferens – karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Genetic Reproductive Profile (Male) | 10-15 days | 1076 |
| GRP | Male Genetic Reproductive Profile | 10-15 days | 1076 |
| GSA | Coeliac/Gluten Sensitivity Profile | 2 days | 195 |
| GSA | Gluten Sensitivity Evaluation | 2 days | 195 |
| GSA2 | Coeliac/Gluten Genetic Profile 2 | 10 days | 410 |
| GSA2 | Gluten/Coeliac Genetic Profile 2 | 10 days | 410 |
| GTT | Glucose Tolerance Test/OGTT | 1 day | 183 |
| GTT + GHDF | Glucose Tolerance with Growth Hormone | 1 day | 306 |
| GTTE | Glucose Tolerance Test (Extended) | 1 day | 301 |
| GTTI | Glucose Tolerance with Insulin | 1 day | 457 |
| GTTS | Glucose Tolerance Test (Short) | 1 day | 117 |
| GTTX | Glucose Tolerance Test (Extended Plus) | 1 day | 338 |
| GUTH | Newborn Screening Panel | 2 weeks | 218 |
| HABC | HLA Tissue Typing A+B+C (Class I) | 10 days | 713 |
| HAIM | Hepatitis A Immunity (IgG/IgM) | 1 day | 62 |
| HANT | Histoplasma Antigen | 3 days | 202 |
| HANV | Hantavirus Serology | 10 days | 158 |
| HAPT | Haptoglobin | 5 days | 87 |
| HAVM | Hepatitis A (IgM) | 1 day | 59 |
| HAVR | Hepatitis A RNA by PCR | 3 weeks | 281 |
| HB | Haemoglobin | 1 day | 38 |
| HBAG | H. pylori Antigen – Stool (RF) | 3 days | 93 |
| HBAG | H. pylori Antigen – Stool (Self-collect) | 3 days | 93 |
| HBE | Hepatitis E IgG/IgM | 5 days | 165 |
| HBEL | Haemoglobin Electrophoresis | 4 days | 121 |
| HBEL | Thalassaemia Screen | 4 days | 121 |
| HBPA | H. pylori Antibodies (IgG) | 2 days | 88 |
| HCGF/PAPA | Down Syndrome Risk Bloods only (Risk to be calculated by clinician) | 1 day | 104 |
| HCGQ | HCG (Oncology) | 1 day | 68 |
| HCO3 | Bicarbonate | 1 day | 29 |
| HCRP | C Reactive Protein (High Sensitivity) (Venous) | 1 day | 62 |
| HCYS | Homocysteine (Urine) | 2 weeks | 156 |
| HDAG | Hepatitis Delta Antigen | 5 days | 179 |
| HDL | HDL Cholesterol | 1 day | 51 |
| HE4 | HE4 + ROMA (Earlier Detection of Ovarian Tumour) | 1 day | 159 |
| HEPD | Hepatitis Delta Antibody | 5 days | 139 |
| HINF | Haemophilus B Influenzae Antibodies | 5 days | 132 |
| HIRP | Hirsutism Profile | 1 day | 212 |
| HISA | Histone Antibodies | 5 days | 128 |
| HISP | Histoplasmosis | 10 days | 173 |
| HITU | Histamine (Urine) | 5 days | 158 |
| HL57 | HLA B*57:01 | 10 days | 401 |
| HL57 | HLA Tissue Typing B*57:01 high resolution | 10 days | 401 |
| HLA | HLA Tissue Typing A | 10 days | 276 |
| HLAB | HLA B27 | 3 days | 256 |
| HLAB | HLA Tissue Typing B*27 only | 3 days | 256 |
| HLAF | HLA Tissue Typing A/B/DRB1/3/4/5 | 10 days | 713 |
| HLB | HLA Tissue Typing B | 10 days | 276 |
| HLBA | HLA Tissue Typing A+B | 10 days | 436 |
| HLC | HLA Tissue Typing C | 10 days | 276 |
| HLDQ | HLA Tissue Typing DRB1/3/4/5/DQB1 (Class II) | 10 days | 436 |
| HLF | HLA Tissue Typing A/B/DRB1/3/4/5/DQB1 | 10 days | 786 |
| HLFC | HLA Tissue Typing A/B/C/DRB1/3/4/5/DQB1 (Class I & II) | 10 days | 932 |
| HMD | Haemochromatosis – HFE common variants C282Y + H63D | 3 days | 269 |
| HMD | HFE gene (Haemochromatosis) – common variants C282Y + H63D | 3 days | 269 |
| HOMO | Homocysteine (Quantitative) | 1 day | 111 |
| HPCU | H. pylori Culture | 1 month | 252 |
| HRT | HRT Profile 1 | 1 day | 129 |
| HRT2 | HRT Profile 2 | 1 day | 197 |
| HSID | Haemosiderin (Urine) | 2 weeks | 128 |
| HSNK | NK Cytotoxicity Assay | Send Mon-Thurs only | 760 |
| HTLP | HTLV by PCR | 21 days | 408 |
| HTLV | HTLV 1 & 2 Abs. (Human T Lymphotropic Virus Type I-II) | 1 day | 76 |
| HVA | Homovanillic Acid (HVA) | 5 days | 121 |
| HVS | HVS | 2-4 days | 93 |
| IBIL | Bilirubin (Indirect) | 1 day | 35 |
| ICAB | Islet Cell Antibodies | 3 days | 82 |
| ICPA | Ionised Calcium | 5 days | 62 |
| IFAB | Intrinsic Factor Antibodies | 2 days | 124 |
| IGA | Immunoglobulin A | 1 day | 50 |
| IGD | Immunoglobulin D | 5 days | 86 |
| IGE | IgE (Total) | 1 day | 68 |
| IGE | Immunoglobulin E – Total | 1 day | 68 |
| IGE | Total IgE | 1 day | 68 |
| IGE | Total Immunoglobulin E | 1 day | 68 |
| IGF2 | Insulin-Like Growth Factor 2 | 1 month | 369 |
| IGG | Immunoglobulin G | 1 day | 50 |
| IGHA | B cell Clonality Assay (IgH and IgK) | 2 weeks | 510 |
| IGM | Immunoglobulin M | 1 day | 50 |
| IGMU | IgVH variant analysis for CLL | 4 weeks | 510 |
| IGSC | IgG Subclasses | 5 days | 279 |
| IHCS | Immunofluorescence in Skin Biopsies | 2 weeks | 613 |
| IL28 | Interleukin 28b Genotype | 2 weeks | 502 |
| IMCP | C1q Binding Immune Complex | 5 days | 121 |
| IMCP | Immune-Complexes | 5 days | 121 |
| IMIP | Imipramine | 4 days | 117 |
| IMM | Immunoglobulins (IgG, IgM, IgA) | 1 day | 100 |
| IMPO | Erectile Dysfunction Profile | 3 days | 281 |
| IMPO | Impotence Profile | 3 days | 281 |
| INAB | Insulin Antibodies | 5 days | 116 |
| INIA | Inhibin A | 1 month | 194 |
| INSU | Insulin | 1 day | 68 |
| INTE | HIV-1 Genotypic Resistance (Integrase) | 21 days | 779 |
| IODI | Iodine – Serum | 1 week | 133 |
| IOP | Iron Overload Profile | 3 days | 346 |
| ISAC | ISAC Panel (Venous) | 3 days | 380 |
| ISP | Iron Status Profile (Venous) | 1 day | 111 |
| IUCD | IUCD for Culture | 11-12 days | 93 |
| K | Potassium | 1 day | 32 |
| KARY | Chromosome Analysis (Blood) | 2-3 weeks | 539 |
| KCCT | APTT/KCCT | 1 day | 50 |
| KETA | Ketamine Screen | 7-10 days | 177 |
| LACG | Lactose Intolerance Gene | 2 weeks | 189 |
| LACT | Lactate (Plasma) | 1 day | 94 |
| LAMO | Lamotrigine | 5 days | 139 |
| LDH | Lactate Dehydrogenase (LDH) | 1 day | 41 |
| LDL7 | LDL7 Subfractions | 10 days | 297 |
| LE | Lysosomal Enzyme Screen | 2 months | 896 |
| LEAD | Lead (Blood) | 5 days | 71 |
| LEGA | Legionella Urine Antigen | 1 day | 119 |
| LEGO | Legionella Antibodies | 3 days | 96 |
| LEIS | Leishmania Antibodies | 5 days | 76 |
| LEL | Lipoprotein Electrophoresis | 5 days | 98 |
| LEP | Leptospirosis (Weil’s Disease) Abs (IgM) | 5 days | 142 |
| LEPT | Leptin | 5 days | 188 |
| LEVE | Levetiracetam (Keppra) | 3 days | 147 |
| LFT | Liver Function Tests (Venous) | 1 day | 63 |
| LH | Luteinising Hormone (LH) (Venous) | 1 day | 63 |
| LIPA | Lipase (Venous) | 1 day | 66 |
| LIPP | Lipid Profile (Venous) | 1 day | 63 |
| LITH | Lithium | 1 day | 59 |
| LIVI | Liver Immunoblot | 3 days | 212 |
| LKM | Liver Kidney Microsomal Antibodies | 2 days | 62 |
| LMPX | Leukaemia Fusion Gene Screening Assay (Q30) | 24 hours | 692 |
| LORA | Lorazepam | 10 days | 82 |
| LPOA | Lipoprotein (a) (Venous) | 1 day | 70 |
| LPR | Lactate Pyruvate Ratio | 4-6 weeks | 166 |
| LSA | Anti-SLA (Soluble Liver Antigen) Abs | 5 days | 142 |
| LSD | LSD | 5 days | 137 |
| LSDS | Lysosomal Storage Disorders NGS Panel – full gene sequencing . Requires patient informed consent | 4-6 weeks | 1078 |
| LTT | Lactose Tolerance Test | 1 day | 175 |
| LUPA | Hughes Syndrome | 2 days | 133 |
| LUPA | Lupus Anticoagulant and Anticardiolipin Abs | 2 days | 133 |
| LUPC | Lupus Anticoagulant only | 2 days | 87 |
| LYPT | Leukaemia Immunophenotyping | 5 days | 666 |
| LYSO | Lysozyme | 5 days | 103 |
| LYSS | CD3/CD4/CD8 | 1 day | 295 |
| LYSS | Lymphocyte Subsets (CD3/CD4/CD8) | 1 day | 295 |
| M2ST | Pyruvate Kinase (M2-PK) | 5 days | 114 |
| MAG | Myelin Associated Glycoprotein Antibodies | 5 days | 373 |
| MALA | Malarial Antibodies (Pl. falciparum) | 5 days | 88 |
| MALP | Malarial Parasites | STAT | 71 |
| MALS | Malarial Antibodies (species specific) | 10 days | 114 |
| MANG | Manganese (Serum) | 5 days | 91 |
| MBOC | MBOCA in Urine | 10 days | 137 |
| MBPA | Myelin Basic Protein Antibodies | 2 weeks | 121 |
| MCV | Mean Cell Volume (MCV) | 1 day | 41 |
| MDR | Carbapenemase producing organism screen | 4-5 days ‡ | 133 |
| MEAM | Measles Antibodies (IgM) | 2 days | 87 |
| MEAP | Measles PCR | 48 hours | 169 |
| MEAS | Measles Antibodies (IgG) Immunity | 1 day | 87 |
| MENI | Meningococcal Serology (only serogroup C) | 6 weeks | 117 |
| MENO | Menopause Profile (Venous) | 1 day | 172 |
| MERC | Mercury (Blood) | 5 days | 71 |
| MERS | MERS Coronavirus Test | 1 day | 212 |
| METQ | Methaqualone | 5 days | 48 |
| METR | Metronidazole Level | 10 days | 117 |
| METS | Metabolic Syndrome Profile | 9 days | 344 |
| METX | Methotrexate | 2 days | 167 |
| MG | Magnesium (Serum) | 1 day | 50 |
| MGE | Myasthenia Gravis Evaluation | 5 days | 198 |
| MICF | Microfilaria Blood Film | STAT | 43 |
| MINE | Mineral Screen | 5 days | 228 |
| MIPR | Male Hormone Profile | 1 day | 211 |
| MMA | Methylmalonic Acid – Urine | 2 weeks | 167 |
| MMAS | Methylmalonic Acid – Serum | 5 days | 268 |
| MMR | Measles, Mumps, Rubella (MMR) | 1 day | 186 |
| MOCP | Stool for OVA Cysts & Parasites by Microscopy | 2 days | 48 |
| MOLY | Molybdenum (Serum) | 5 days | 90 |
| MP48 | Malarial Parasites (visa, non-urgent) | 2 days | 71 |
| MPCP | Pneumocystis jiroveci (PJP) PCR | 2-3 days | 120 |
| MPCR | Mycoplasma species – DNA | 5 days | 260 |
| MPNS | Myeloproliferative Neoplasm NGS Screening Panel . Requires patient informed consent | 1 week | 634 |
| MPO | Myeloperoxidase Antibodies | 2 days | 70 |
| MRS2 | MRSA (Rapid PCR) one swab per site x 2 | 1 day | 177 |
| MRS2 | MRSA PCR (Self-collect) – Nose/Groin | 1 day | 177 |
| MRSA | MRSA (Rapid PCR) one swab per site | 1 day | 89 |
| MRSW | MRSA Culture one swab per site | 2 days | 63 |
| MRW2 | MRSA Culture one swab per site x 2 | 2 days | 127 |
| MRW2 | MRSA Culture (Self-collect) – Nose/Groin | 2 days | 127 |
| MSTT | Testosterone (Total), LC MS Mass Spec | 5-7 days | 129 |
| MSTT | Total Testosterone, LC MS Mass Spec | 5-7 days | 129 |
| MTHF | MTHFR – common C677T + A1298C variants | 5 days | 276 |
| MTM2 | Mitochondrial Antibodies M2 | 2 days | 272 |
| MUMM | Mumps Antibodies (IgM) | 1 day | 87 |
| MUMP | Mumps Antibodies (IgG) | 1 day | 87 |
| MUSK | Anti-MUSK Antibodies | 2 weeks | 392 |
| MVPS | Myeloid Gene Panel . Requires patient informed consent | 2 weeks | 760 |
| MYCO | Mycoplasma pneumoniae IgM and IgG | 2 days | 77 |
| MYCP | Mycophenolic Acid (Cellcept) | 5 days | 167 |
| MYEL | Myeloma Screen | 5 days | 183 |
| MYO | Myocardial Antibodies | 1 week | 94 |
| MYOS | Myositis Panel | 3 days | 137 |
| NA | Sodium | 1 day | 32 |
| NASS | Swab (Nasal) | 2-4 days | 93 |
| NCIT | Suppression with steroid, IVIg and intralipin, NK (CD69) cell assay, TH1/TH2 cytokines | Send Mon-Thurs only | 1216 |
| NCOV | COVID-19 (SARS-CoV-2) (PCR) | 1 day | 215 |
| NCOV | COVID-19 (SARS-CoV-2) RNA by PCR (Self-collect) | 1 day | 215 |
| NEUR | Neuronal Antibody (Hu, Ri, Yo, Cv2, Ma2) | 10 days | 357 |
| NICK | Nickel (Serum) | 5 days | 90 |
| NICU | Nickel (Urine) | 4 weeks | 96 |
| NIPT | Non-Invasive Prenatal Testing (NIPT) – common aneuploidy screening from maternal blood | 2-4 days | 339 |
| NKCY | NK Cytotoxicity with suppression, steroid, IVIg & Intralipin | Send Mon-Thurs only | 970 |
| NKP2 | Natural Killer Profile 2 | 2 days | 324 |
| NMDA | NMDA Receptor Antibodies | 3 weeks | 262 |
| NSE | Neurone Specific Enolase | 5 days | 211 |
| NSI | Needle Stick Injury Profile | 1 day | 220 |
| NVIR | Neurological Viral Screen | 2 days | 218 |
| OCP | Cryptosporidium | 2 days | 93 |
| OEST | Oestradiol-17-Beta (Venous) | 1 day | 63 |
| OLAN | Olanzapine | 5 days | 147 |
| OMG3 | Omega 3/Omega 6 (Venous) | 5 days | 149 |
| OPS | Osteoporosis Screen | 4 days | 205 |
| ORSW | Swab (Oral) | 2-4 days | 92 |
| OSMO | Osmolality (Serum) | 1 day | 61 |
| OVAB | Ovarian Autoantibodies | 3 days | 88 |
| P1NP | Procollagen 1 Peptide N-Terminal (NTX) | 5 days | 343 |
| PAIP | PAI-1 4G/5G Polymorphism | 10 days | 237 |
| PALB | Prealbumin | 3 days | 102 |
| PAPT | Cervical Cytology | 6 days (combined report) | 56 |
| PAPT + HP20 | Cervical Cytology + HP20 | 6 days (combined report) | 232 |
| PARA | Paracetamol | 1 day | 138 |
| PARG | Parvovirus Antibodies (IgG) | 2 days | 97 |
| PARP | Parvovirus IgG/IgM Abs | 2 days | 110 |
| PARV | Parvovirus Antibodies (IgM) | 2 days | 108 |
| PASS | Pneumococcal Antibodies – Serotype Specific | 5 weeks | 311 |
| PAUL | Paul Bunnell (Monospot) | 1 day | 31 |
| PCOP | Polycystic Ovary Syndrome Profile | 5 days | 661 |
| PCOS | Polycystic Ovary Syndrome SHORT | 1 day | 210 |
| PCRB | Babesia PCR | 7 days | 125 |
| PCRP | Human Parvovirus B19 – DNA | 2 weeks | 244 |
| PENS | Swab (Penile) | 2-4 days | 92 |
| PENT | Stool for OCP and Culture by PCR | 2-3 days | 44 |
| PERP | Pertussis (Whooping Cough) by PCR | 2-3 days | 199 |
| PERP | Whooping Cough (Pertussis) by PCR | 2-3 days | 199 |
| PERS | Pertussis (Whooping Cough) Antibodies | 5 days | 107 |
| PERS | Whooping Cough (Pertussis) Antibodies | 5 days | 107 |
| PETH | PEth (Phosphatidylethanol) (Venous) | 5-7 days | 129 |
| PFAT | Platelet Function Test Screen – PFA-100/200 | 1 day | 190 |
| PHB | Phenobarbitone | 1 day | 75 |
| PHEN | Epanutin (Phenytoin) | 1 day | 75 |
| PHEN | Phenytoin (Epanutin) | 1 day | 75 |
| PHFP | Leukaemia/Lymphoma RNA Sequencing (Fusion Gene and SNV/Indel) Panel . Requires patient informed consent | 2 weeks | 1078 |
| PHOS | Phosphate | 1 day | 32 |
| PHTS | Anti-Phosphatidylserine Antibodies | 5 days | 173 |
| PITF | Pituitary Function Profile | 1 day | 234 |
| PITU | Pituitary Antibodies | 1 month | 119 |
| PLA2 | Lp-PLA2 (PLAC) Test | 2 days | 142 |
| PLA2 | PLAC Test (Lp-PLA2) (Venous) | 2 days | 142 |
| PLAG | Platelet Aggregation Studies | 3 days | 385 |
| PNAG | Pneumococcal Antigen | 1 day | 120 |
| PNEU | Pneumococcal Antibody Screen | 5 days | 129 |
| POMP | Glycogen storage disease type 2 (Pompe) variant analysis | 4 weeks | 1193 |
| PORP | Porphyrin (Blood) | 15 days | 263 |
| PORS | Porphyrin Full Screen (Total: Urine, Stool, Blood) | 3 weeks | 599 |
| PP | Pancreatic Peptide | 4 weeks | 266 |
| PR2 | Prostate Profile (Total & Free PSA) | 1 day | 111 |
| PR3 | Proteinase 3 Ab | 2 days | 68 |
| PRCO | Procollagen 3 Peptide | 5 days | 192 |
| PREG | Pregnancy Test (Urine) | 1 day | 46 |
| PREN | Pregnenolone | 15 days | 142 |
| PRGM | Paragomius Serology | 2 weeks | 163 |
| PRIM | Mysoline (Primidone) | 3 days | 88 |
| PRIM | Primidone (Mysoline) | 3 days | 88 |
| PRLD | Macroprolactin | 4 days | 298 |
| PRLD | Prolactin (Macro) | 4 days | 298 |
| PRO | Propanalol | 7 days | 132 |
| PROG | Progesterone (Venous) | 1 day | 63 |
| PROL | Prolactin (Venous) | 1 day | 63 |
| PROP | Miscarriage/Thrombotic Risk Profile | 5 days | 873 |
| PROP | Thrombotic Risk Profile | 5 days | 873 |
| PROT | Protein Total (Blood) | 1 day | 32 |
| PROZ | Fluoxetine (Prozac) | 5 days | 147 |
| PRTE | Protein Electrophoresis incl. immunoglobulin | 5 days | 129 |
| PSPA | Prostate Specific Antigen (Total) (Venous)* | 1 day | 82 |
| PTHA | Parathyroid Antibodies | 3 weeks | 113 |
| PTHI | Parathyroid Hormone (Whole) | 1 day | 144 |
| PTIM | INR | 1 day | 35 |
| PTIM | Prothrombin Time | 1 day | 35 |
| PTS | Post-Travel Screen 1 (Up to 6 weeks post travel) | 10 days | 309 |
| PTS2 | Post-Travel Screen 2 (6 weeks after travel) | 10 days | 581 |
| PURK | Purkinje Cell Antibody (Hu and Yo) | 10 days | 76 |
| PWAM | Angelman Syndrome (Primary Screen) – methylation test | 10 days | 570 |
| PWAM | Prader-Willi Syndrome (Primary Screen) – methylation test | 10 days | 570 |
| Q2Q8 | Coeliac Disease – HLA DQ2/DQ8 Genotype | 10 days | 240 |
| Q2Q8 | HLA Tissue Typing Coeliac Disease – DQ2/DQ8 | 10 days | 240 |
| QCAL | Calprotectin/QFIT Profile (Combined) (QFIT) | 5 days | 177 |
| QCAL | Calprotectin/QFIT Profile (Combined) (Self-collect) | 5 days | 177 |
| QCAL | QFIT/Calprotectin Profile (Combined) (QFIT) | 5 days | 177 |
| QCAL | QFIT/Calprotectin Profile (Combined) (Self-collect) | 5 days | 177 |
| QCYS | Cystine – Quantitative (Beta-CTX) | 5 days | 150 |
| QFEV | Q Fever (C Burnetti) Antibodies | 10 days | 83 |
| QFIT | Quantitative Faecal Immunochemical Test (QFIT) | 1 day | 68 |
| QFIT | Quantitative Faecal Immunochemical Test (QFIT) (Self-collect) | 1 day | 68 |
| QHCG | HCG (Quantitative) (Venous) | 1 day | 70 |
| QHCG | Pregnancy (Serum) [Quantitative] | 1 day | 70 |
| QPCR | Hepatitis C Quantification (Viral Load) | 5 days | 286 |
| R90U | Bleeding and Platelet Gene Panel . Requires patient informed consent | 12 weeks | 1309 |
| R90U | Inherited bleeding and platelet disorders (R90) | 12 weeks | 1309 |
| R97U | Thrombophilia with a likely monogenic cause (R97) | 12 weeks | 1309 |
| RABI | Rabies Antibody | 20 days | 185 |
| RAPS | Rapid Strep PCR (incl. m/c/s) | 1-3 days** | 96 |
| RBCF | Folate (Red Cell) | 2 days | 60 |
| RBCF | Vitamin B9 (Folic acid) – Red cell | 2 days | 60 |
| RBCZ | Zinc (Whole Blood) | 5 days | 62 |
| RBG | Glucose | 1 day | 33 |
| RBGM | Glucose Challenge Test/Mini-GTT | 1 day | 38 |
| RBJP | Bence-Jones Protein | 5 days | 117 |
| RBP | Retinol Binding Protein | 3 days | 76 |
| RCMG | Magnesium (Whole blood) | 4 days | 111 |
| RECG | Swab (Rectal) | 2-4 days | 93 |
| RETC | Reticulocyte Count | 1 day | 38 |
| RF | Rheumatoid Factor (Latex Test) | 3 days | 41 |
| RH | Rheumatology Profile 1 (Screen) | 2 days | 165 |
| RH2 | Rheumatology Profile 2 (Connective tissue) | 3 days | 487 |
| RH3 | Rheumatology Profile 3 (Rheumatoid/Basic) | 2 days | 238 |
| RH4 | Rheumatology Profile 4 (Systemic Lupus) | 2 days | 366 |
| RH5 | Rheumatology Profile 5 (Mono Arthritis) | 3 days | 350 |
| RH6 | Rheumatology Profile 6 (Rheumatoid Plus) | 3 days | 121 |
| RH7 | Rheumatology Profile 7 (Sjogren’s Syndrome) | 15 days | 121 |
| RH7 | Sjogren’s Syndrome | 15 days | 121 |
| RIBA | Hepatitis C Abs Confirmation (RIBA) | 5 days | 216 |
| RICK | Rickettsial Species Antibody Profile | 7 days | 133 |
| RISP | Risperidone | 7 days | 227 |
| RMIN | Mineral Screen (Whole blood) | 5 days | 248 |
| RMP | Recurrent Miscarriage Profile (female) | 10-15 days | 1277 |
| RNAP | RNA Polymerase Antibodies | 3 days | 81 |
| ROSM | Osmolality (Urine) | 1 day | 59 |
| ROTA | Rotavirus in Stool by PCR | 1 day | 119 |
| RPOR | Porphyrin (Urine) | 3 weeks | 194 |
| RSPR | Renal Calculi Screen (Metabolic) | 5 days | 212 |
| RSTA | Gall Stone Analysis | 10 days | 219 |
| RSTA | Renal Stone Analysis | 10 days | 219 |
| RT3 | Reverse T3 | 15 days | 156 |
| RT3 | T3 (Reverse) | 15 days | 156 |
| RU5H | 5 HIAA | 5 days | 119 |
| RUAL | Aminolevulinic Acid (Urine) | 5 days | 81 |
| RUAV | Rubella Avidity | 1 week | 173 |
| RUBE | Rubella Antibody (IgG) | 1 day | 64 |
| RUBM | Rubella Antibody (IgM) | 1 day | 91 |
| RUBP | Rubella PCR | 5 days | 207 |
| S100 | S100 Malignant Melanoma | 4 days | 158 |
| SAA | Amyloidosis (Amyloid A Protein) | 5 days | 124 |
| SAB | Salivary Duct Antibodies | 15 days | 71 |
| SALI | Salicylates | 1 day | 67 |
| SCA | Steroid Cell Antibody | 2 days | 111 |
| SCC | Squamous Cell Carcinoma | 4 days | 243 |
| SCLI | Scleroderma Immunoblot | 3 days | 212 |
| SCOV | COVID-19 (SPIKE) Antibodies (Venous) | 1 day | 63 |
| SDPD | Crosslaps (Serum DPD) | 4 days | 123 |
| SDPD | Deoxypyridinoline (DPD) – Serum | 4 days | 123 |
| SELE | Selenium (Serum) (Venous) | 4 days | 88 |
| SELL | Sellotape Test | 1 day | 96 |
| SGAL | Galactomanan (Aspergillus Antigen) | 2 weeks | 190 |
| SHBG | Sex Hormone Binding Globulin (Venous) | 1 day | 75 |
| SILV | Silver (Blood) | 5 days | 124 |
| SIRO | Sirolimus | 3 days | 154 |
| SKAB | Pemphigus/Pemphigoid Autoantibodies | 2 days | 75 |
| SKAB | Skin (Pemphigus/Pemphigoid) Autoantibodies | 2 days | 75 |
| SKIS | Swab (Skin) | 2-4 days | 93 |
| SLC | Serum Free Light Chains | 5 days | 376 |
| SMA | Spinal Muscular Atrophy – SMN1 deletions/duplications | 10 days | 567 |
| SMYO | Myoglobin (Serum) | 1 day | 87 |
| SODI | Superoxide Dismutase | 5 days | 123 |
| SPOR | Sports/Performance Profile | 5 days | 635 |
| SPU1 | Sputum for Routine Culture | 2-4 days | 102 |
| SPU2 | Sputum for TB Culture (AFB) | up to 8 weeks | 102 |
| SPU2 | TB Culture | up to 8 weeks | 102 |
| SRY | SRY (Sex-determining Region Y) | 2 days | 234 |
| STGA | Strongyloides Antibodies | 10 days | 136 |
| STK3 | Stockholm3 | 2 weeks | 356 |
| STKR | Stockholm3 Reflex | 2 weeks | 356 |
| STRA | Striated/Skeletal Muscle Antibody | 3 days | 62 |
| STRM | Streptomycin Levels | 5 days | 197 |
| STRS | Stool Reducing Substances | 2-3 weeks | 63 |
| STRY | Tryptase | 2 days | 181 |
| STSK | Skin Antibodies by Immunofluorescence | 1 month | 282 |
| SULP | Sulpiride | 4 days | 139 |
| SYNA | Synacthen Stimulation Test | 1 day | 306 |
| T3 | T3 | 1 day | 63 |
| T4 | Thyroxine (T4) | 1 day | 58 |
| TAA | Tissue Transglutaminase IgA (Coeliac) (Venous)** | 2 days | 76 |
| TAAG | Tissue Transglutaminase IgG | 5 days | 90 |
| TB12 | Vitamin B12 (Total) | 1 day | 66 |
| TBCU | TB (Pleural Fluid) | up to 8 weeks | 102 |
| TBPC | TB PCR (PCR detection of Mycobacterium tuberculosis complex and mutations for Rifampicin resistance) | 1 day | 228 |
| TBQ4 | TB Quantiferon®-TB Gold* | 3 days | 136 |
| TBSL | TB Slopes – Confirmation and Sensitivity | up to 8 weeks | 241 |
| TBUR | TB Culture (Urine) | up to 8 weeks | 217 |
| TCRA | T cell Clonality Assay (TCR beta and TCR gamma) | 2 weeks | 510 |
| TDM | HIV Therapeutic Drug Monitoring | 21 days | 319 |
| TDYE | Toxoplasma Antibody Full Evaluation (IgM, Dye Test, IgG Avidity) | 10 days | 172 |
| TEIC | Teicoplanin Assay | 5 days | 139 |
| TEMA | Temazepam | 4 days | 154 |
| TEST | Testosterone (Venous) | 1 day | 63 |
| TETA | Tetanus Antibody | 5 days | 128 |
| TF | Thyroid Profile 1 (FT4/TSH) (Venous) | 1 day | 88 |
| TF2 | Thyroid Profile 2 (Venous) | 2 days | 209 |
| TF3 | Thyroid Profile 3 (FT3/FT4/TSH) (Venous) | 1 day | 125 |
| TFAM | Toxoplasma Antibodies (IgG, IgM) | 1 day | 94 |
| TFAT | Toxocara Antibodies (IgG) | 5 days | 94 |
| TFFA | Faecal Fat (1 day collection) | 5 days | 185 |
| TFIF | Bancroftia/Oncerciasis/Filarial Antibodies | 2 weeks | 196 |
| TGA | Thyroglobulin Assay | 1 day | 111 |
| TGAB | Thyroglobulin Abs | 1 day | 64 |
| TGN | 6-Thioguanine Nucleotides | 2 weeks | 208 |
| THAB | Thyroid Abs (Thyroglobulin + Thyroid Peroxidase Abs) (Venous) | 1 day | 105 |
| THAL | Thallium (Blood) | 1 week | 90 |
| THEO | Theophylline | 1 day | 66 |
| THRO | Thrombin Time | 1 day | 40 |
| THRS | Swab (Throat) | 2-4 days | 93 |
| TIE | Immune Function Evaluation (Total) | 7 days | 424 |
| TIE | Total Immune Function Evaluation | 7 days | 424 |
| TISS | Tissue for culture | up to 14 days | 102 |
| TOBR | Tobramycin Assay (Provide Clinical Details) | 3 days | 248 |
| TOL | Toluene (Blood) | 10 days | 171 |
| TOPI | Topiramate (Topamax) | 4 days | 132 |
| TORC | Torch Screen | 2 days | 228 |
| TPA | Tissue Polypeptide Antigen | 1 week | 208 |
| TPEX | Thyroid Peroxidase Antibodies/Anti TPO | 1 day | 64 |
| TPMT | Thiopurine Methyl Transferase | 5 days | 173 |
| TRAC | Mineral Screen and Industrial Heavy Metal Screen (Trace Metals) | 7-10 days | 360 |
| TRAC | Trace Metal (Blood) Profile | 7-10 days | 360 |
| TRAN | Transferrin | 1 day | 98 |
| TREL | Transferrin Electrophoresis | 2 weeks | 317 |
| TRI | Triglycerides | 1 day | 38 |
| TRIC | Trichinella Serology | 5 days | 119 |
| TRIM | Trimipramine | 5 days | 110 |
| TROC | Troponin I (High sensitive) | 1 day | 114 |
| TROP | Tropical Screen (from 6 weeks post-travel) | 10 days | 263 |
| TROT | Troponin T (High sensitive) | 1 day | 124 |
| TRPM | HIV-1 Tropism | 28 days | 1194 |
| TRYP | Sleeping Sickness Serology (African Trypanosomiasis) | 10 days | 239 |
| TSH | TSH (Venous) | 1 day | 63 |
| TSI | TSH-Receptor Antibodies | 4 days | 190 |
| TTP | Testicular Tumour Profile (LDH, AFP, HCQG) | 1 day | 154 |
| TTVT | Taipan Snake Venom Time | 2-3 weeks | 289 |
| TULA | Tularaemia Antibodies | 5 days | 123 |
| TXAG | Toxoplasma by PCR | 5 days | 197 |
| U/E | Urea and Electrolytes | 1 day | 64 |
| UA | Urate (Uric acid) | 1 day | 38 |
| UA | Uric Acid (Serum) | 1 day | 38 |
| UALC | Alcohol (Urine) | 1 day | 97 |
| UALD | Aldosterone (Urine) | 5 days | 160 |
| UAMY | Amylase (Urine) | 1 day | 59 |
| UB2M | Beta 2 Microglobulin (Urine) | 3 days | 125 |
| UBC | Urinary Bladder Cancer Antigen | 5 days | 106 |
| UCA | Calcium (24 hour Urine) | 1 day | 38 |
| UCAT | Catecholamines (Urine) | 5 days | 181 |
| UCEM | Urine Chemistry, Microscopy and Culture (Self-collect) | 1-2 days | 78 |
| UCEM | Urine for Microscopy and Culture | 1-2 days | 78 |
| UCOC | Cocaine (Urine) Screen | 1 day | 36 |
| UCOR | Cortisol (Urine) | 5 days | 90 |
| UCPR | Protein/Creatinine Ratio (Urine) | 1 day | 88 |
| UCR | Creatinine (Urine) | 1 day | 48 |
| UCXD | Urine for Extended Culture | up to 7 days | 169 |
| UDHE | DHEA – Urine (Dehydroepiandrosterone) | 3 weeks | 119 |
| UELE | Electrolytes (Urine) | 1 day | 50 |
| UFL | Fluoride (Urine) | 5 days | 137 |
| UHYD | Hydroxyprolene | 2 weeks | 114 |
| UIOD | Iodide – Urine | 1 week | 159 |
| UMA | Urine Microalbumin/Creatinine Ratio | 1 day | 88 |
| UMEL | Melatonin (Urine) | 2 weeks | 166 |
| UMEX | Metanephrines (Urine) | 5 days | 172 |
| UMIC | Urine (Microscopy Only) | 1 day | 60 |
| UMIC | Urine Chemistry and Microscopy (Self-collect) | 1-2 days | 60 |
| UMYO | Myoglobin (Urine) | 5-10 days | 123 |
| UOLI | Oligosaccharides | 6 weeks | 274 |
| UOPI | Opiate Screen (Urine) | 2 days | 68 |
| UOXA | Oxalate (Urine) | 5 days | 103 |
| UPH | Phosphate (24 hour Urine) | 1 day | 50 |
| UPRT | Protein (Urine) | 1 day | 48 |
| URCD | Cadmium (Urine) | 5 days | 96 |
| URCR | Chromium (Urine) | 4 weeks | 84 |
| URCU | Copper (Urine) | 5 days | 71 |
| URCY | Urine Cytology (Urine cytology containers available from TDL Supplies) | 2 days | 174 |
| UREA | Urea (Venous) | 1 day | 38 |
| URES | Swab (Urethral) | 2-4 days | 93 |
| URHG | Mercury (Urine) | 5 days | 96 |
| URMG | Magnesium (Urine) | 1 day | 55 |
| URPB | Lead (Urine) | 5 days | 71 |
| URTH | Thallium (Urine) | 1 week | 90 |
| URZN | Zinc (Urine) | 5 days | 63 |
| USCH | Bilharzia (Urine) | 1-2 days | 84 |
| USCH | Schistosoma (Urine) | 1-2 days | 84 |
| USIL | Silver (Urine) | 5 days | 124 |
| USTE | Urine Steroid Screen (Steroid Hormones) | 2 weeks | 967 |
| UTCA | Trichloracetic Acid (Urine) | 5 days | 166 |
| UTOL | Toluene (Urine) | 10 days | 220 |
| UURE | Urea (Urine) | 1 day | 38 |
| UURI | Uric Acid (Urine) | 1 day | 51 |
| UVMA | VMA | 5 days | 87 |
| UXYL | Xylene – Urine | 2 weeks | 124 |
| VAGS | Swab (Vaginal) | 2-4 days | 93 |
| VALP | Valproic Acid (Epilim) | 1 day | 66 |
| VANC | Vancomycin Hydrochloride | 1 day | 110 |
| VB5S | Vitamin B5 (Pantothenic Acid) | 5 days | 159 |
| VBP | Vitamin B Profile | 5 days | 546 |
| VEGF | Vascular Endothelial Growth Factor | 14 days | 261 |
| VIB2 | Vitamin B2 (Riboflavin) | 5 days | 183 |
| VIB3 | Vitamin B3 (Nicotinamide) | 5 days | 183 |
| VIGA | Vigabatrin (Sabril) | 10 days | 132 |
| VIP1 | Chronic Fatigue Syndrome Profile | 5 days | 470 |
| VIRA | Viral Antibody Screen | 2 days | 218 |
| VISC | Viscosity (Plasma) | 3 days | 68 |
| VIT1 | Vitamin B1 (Thiamine) | 5 days | 183 |
| VIT2 | Vitamin Profile 2 | 5 days | 570 |
| VITA | Vitamin A (Retinol) | 5 days | 183 |
| VITB | Vitamin B6 (Pyridoxine) | 5 days | 183 |
| VITD | Vitamin D (25-OH) (Venous) | 1 day | 96 |
| VITE | Vitamin E (Alpha Tocopherol) | 5 days | 192 |
| VITS | Vitamin Profile 1 | 5 days | 380 |
| VKN | Vitamin K (Nutritional) | 5 days | 104 |
| VLDL | VLDL Cholesterol | 1 week | 98 |
| VPCA | Voltage Gated Potassium Channel Antibodies | 3 weeks | 225 |
| VPE | Viral Eye by PCR | 3 days | 147 |
| VPR | Viral Respiratory RNA Screen by PCR | 2 days | 377 |
| VPR | Viral Respiratory RNA Screen by PCR (Self-collect) | 2 days | 377 |
| VPSK | Viral Skin/Mucosa by PCR | 5 days | 132 |
| VULV | Swab (Vulval) | 2-4 days | 93 |
| VWM | Von Willebrands Multimers | 3 months | 728 |
| VZOM | Varicella zoster Antibodies (IgM) | 1 day | 91 |
| VZOS | Varicella zoster Antibodies (IgG) | 1 day | 91 |
| VZPC | Varicella zoster – DNA | 5 days | 328 |
| WNV | West Nile Virus Abs | 2 weeks | 281 |
| WOUS | Swab (Wound) | 2-4 days | 93 |
| XANB | Xanthine – Blood | 2 weeks | 125 |
| XBDG | Beta D Glucan | 3 days | 150 |
| XDNA | DNA Extraction & Storage – 3 years (longer upon request) | 20 days | 212 |
| YDEL | Chromosome Y Deletion – AZFa, AZFb, AZFc + SRY | 5 days | 291 |
| YDEL | Y chromosome microdeletions – AZFa + AZFb + AZFc + SRY | 5 days | 291 |
| YELL | Yellow Fever Antibodies | 10 days | 206 |
| YERS | Yersinia Antibodies | 4 days | 208 |
| ZIKA | Zika RT PCR – Window of detection from 1-7 days from onset of symptoms | Up to 14 days | 262 |
| ZIKU | Zika RT PCR – Window of detection from 1-14 days from onset of symptoms | Up to 14 days | 262 |
| ZINC | Zinc (Serum) | 2 days | 59 |
| ZKAB | Zika Abs IgM and IgG – Antibody detection from 15 days | Up to 14 days | 148 |
| ZZ1 | Alternaria Components | 2 days | 81 |
| ZZ10 | Fish Components | 2 days | 119 |
| ZZ11 | Hazelnut Components | 2 days | 196 |
| ZZ12 | House Dust Mite Components | 2 days | 156 |
| ZZ13 | Latex Components | 2 days | 346 |
| ZZ14 | Olive Components | 2 days | 81 |
| ZZ15 | Peach Components | 2 days | 156 |
| ZZ16 | Peanut Components | 2 days | 233 |
| ZZ17 | Shrimp Components | 2 days | 81 |
| ZZ18 | Soybean Components | 2 days | 156 |
| ZZ19 | Timothy Grass Components | 2 days | 346 |
| ZZ2 | Aspergillus Components | 2 days | 233 |
| ZZ20 | Wall Pellitory Components | 2 days | 81 |
| ZZ21 | Wheat Components | 2 days | 158 |
| ZZ22 | PR-10 Proteins | 2 days | 315 |
| ZZ23 | Lipid Transfer Proteins | 2 days | 274 |
| ZZ24 | Profilins | 2 days | 311 |
| ZZ25 | Polcalcins | 2 days | 119 |
| ZZ26 | Seed Storage Proteins | 2 days | 308 |
| ZZ27 | Glycan Determinants | 2 days | 81 |
| ZZ28 | Lipocalins | 2 days | 119 |
| ZZ29 | Parvalbumins | 2 days | 119 |
| ZZ3 | Birch Components | 2 days | 196 |
| ZZ30 | Serum Albumins | 2 days | 230 |
| ZZ31 | Tropomyosins | 2 days | 119 |
| ZZ32 | Kiwi Components | 2 days | 76 |
| ZZ33 | Venom Components | 2 days | 188 |
| ZZ34 | Walnut Components | 2 days | 119 |
| ZZ35 | Cashew Components | 2 days | 81 |
| ZZ36 | Apple Components | 2 days | 119 |
| ZZ37 | Alpha Gal Components (related to red meat) | 2 days | 81 |
| ZZ38 | Horse Components | 2 days | 46 |
| ZZ39 | Sesame Components | 2 days | 46 |
| ZZ4 | Brazil Components | 2 days | 81 |
| ZZ5 | Cat Components | 2 days | 119 |
| ZZ6 | Celery Components | 2 days | 81 |
| ZZ7 | Cow’s Milk Components | 2 days | 233 |
| ZZ8 | Dog Components | 2 days | 156 |
| ZZ9 | Egg Components | 2 days | 233 |
| APC | QF-PCR rapid common aneuploidy screen | 2 days | 335 |
| CGH | Array-CGH (Comparative Genomic Hybridisation) SNP array | 10 days | 945 |
| CGH | Comparative Genomic Hybridisation (CGH) SNP array | 10 days | 945 |
| DGB | 22q11 & 10p14 deletion (Di George Syndrome) – BOBs only | 5 days | 298 |
| DGB | DiGeorge Syndrome (22q11 & 10p14) - BOBs only | 5 days | 298 |
| DGB, KARY | DiGeorge Syndrome (22q11 & 10p14 deletion) - BOBs (5 days) + karyotype (15 days) | 5-15 days | 837 |
| DGB,KARY | 22q11 & 10p14 deletion (Di George Syndrome) – BOBs (5 days) + karyotype (15 days) | 5-15 days | 837 |
| GENE | Alpha-1-Antitrypsin Genotype - PI*M, PI*S, PI*Z | 3 weeks | 381 |
| GENE | C-KIT D816V variant - Mastocytosis | 4 weeks | 320 |
| GENE | Fragile X Syndrome screen - FMR1 repeat analysis PCR | 5 weeks | 427 |
| GENE | AML/ALL Molecular MRD - NPM1, PML-RARA, CBFB-MYH11, RUNX1-RUNX1T1, ETV6-RUNX1 | 5 days | 482 |
| GENE | Narcolepsy (HLA DQB1*06:02) | 3 weeks | 543 |
| GENE | IDH1/2 Screening Assay | 48 hours | 826 |
| GENE | Familial Hypercholesterolaemia NGS panel | 6 weeks | 761 |
| GENE | 21-Hydroxylase Deficiency (Congenital Adrenal Hyperplasia CYP21A2) |
5 weeks | 862 |
| GENE | Alpha Thalassaemia - multiplex PCR for common large deletions | 3 weeks | 320 |
| GENE | Alpha Thalassaemia - alpha globin gene sequencing + deletions/duplications | 4 weeks | 960 |
| GENE | Adenomatous Polyposis NGS Panel | 4 weeks | 1400 |
| GENE | Achromatopsia NGS Panel | 5 weeks | 2560 |
| GENE | Aicardi-Goutières Syndrome NGS Panel | 5 weeks | 2560 |
| GENE | Alagille Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Alport Syndrome NGS Panel - full sequencing with deletions and duplications | 5 weeks | 2560 |
| GENE | Alzheimer and Dementia NGS Panel | 6 weeks | 2560 |
| GENE | Systemic Mastocytosis - C-Kit common variants (KIT D816V) | 4 weeks | 320 |
| GENE | Friedreich Ataxia – frataxin gene repeat analysis | 5 weeks | 480 |
| GENE | Gilbert Syndrome - common UGT1A1 repeat variation | 2-3 weeks | 480 |
| GENE | Kennedy Disease (Spinal Bulbar Muscular Atrophy) - AR repeat expansion | 5 weeks | 480 |
| GENE | Spinal Bulbar Muscular Atrophy (Kennedy Disease) - AR repeat analysis | 5 weeks | 480 |
| GENE | HLA Tissue Typing Narcolepsy - DQB1*06:02 | 3 weeks | 559 |
| GENE | Huntington Disease - HD gene repeat analysis PCR | 5 weeks | 560 |
| GENE | Myotonic Dystrophy Type 1 - DMPK repeat PCR | 5 weeks | 560 |
| GENE | Myotonic Dystrophy Type 2 (PROMM) - ZNF9 repeat PCR | 6 weeks | 560 |
| GENE | Leber’s Hereditary Optic Neuropathy – m.3460G>A + m.11778G>A + m.14484T>C common variants | 6 weeks | 672 |
| GENE | Ashkenazi Breast Cancer Screen - common variants | 4 weeks | 680 |
| GENE | Breast Cancer Ashkenazi Screen - common variants | 4 weeks | 680 |
| GENE | Charcot-Marie-Tooth Type 1A - PMP22 duplications | 6 weeks | 680 |
| GENE | Hereditary Neuropathy with Liability to Pressure Palsy - PMP22 deletion analysis | 6 weeks | 680 |
| GENE | Breast Cancer - BRCA1 + BRCA2 genes only | 4 weeks | 720 |
| GENE | Spinocerebellar Ataxia - multiplex SCA1+2+3+6+7+8+10+12+17 common repeat expansions | 5 weeks | 880 |
| GENE | Ashkenazi Jewish Carrier Screen | 4 weeks | 960 |
| GENE | Beckwith-Wiedemann Syndrome - methylation studies on 11p15 imprinting domains KvDMR + H19 | 6 weeks | 960 |
| GENE | Beta Thalassaemia - beta-globin gene sequencing + deletions/duplications | 4 weeks | 960 |
| GENE | Carrier Screen (Ashkenazi Jewish) | 4 weeks | 960 |
| GENE | Carrier Screen (Pan-Ethnic) | 4 weeks | 960 |
| GENE | Silver-Russell Syndrome - methylation studies on 11p15 imprinting domains KvDMR + H19 | 7 weeks | 960 |
| GENE | Tay Sachs Screen | 4 weeks | 960 |
| GENE | Familial Medullary Thyroid Carcinoma - hotspot sequencing RET gene | 6-7 weeks | 1120 |
| GENE | Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency - full G6PD gene sequencing | 3-4 weeks | 1120 |
| GENE | Multiple Endocrine Neoplasia Type 2 - RET gene hotspot sequencing | 6-7 weeks | 1120 |
| GENE | Li-Fraumeni Syndrome (p53-related cancer predisposition) - TP53 sequencing + MLPA | 6 weeks | 1176 |
| GENE | p53-related cancer predisposition (Li-Fraumeni Syndrome) - TP53 sequencing + MLPA | 6 weeks | 1176 |
| GENE | Renal Cysts and Diabetes (RCAD) - HNF-1β sequencing exons 1-9 and dosage analysis by MLPA | 8 weeks | 1176 |
| GENE | Fabry Disease, X-linked - GLA gene sequencing | 4 weeks | 1184 |
| GENE | Androgen Insensitivity - AR gene sequencing | 5 weeks | 1200 |
| GENE | Aniridia, Isolated - PAX6 gene sequencing + deletions/duplications | 5 weeks | 1200 |
| GENE | CADASIL - NOTCH3 gene sequencing | 6 weeks | 1200 |
| GENE | Carrier Screen (Ashkenazi Jewish) - Partnered Report | 4 weeks | 1200 |
| GENE | Carrier Screen (Pan-Ethnic) - Partnered Report | 4 weeks | 1200 |
| GENE | CHARGE Syndrome - CHD7 gene sequencing | 6 weeks | 1200 |
| GENE | Duchenne Muscular Dystrophy - full sequencing DMD1 gene | 6 weeks | 1200 |
| GENE | Familial Mediterranean fever - MEFV gene sequencing | 5 weeks | 1200 |
| GENE | Gaucher Disease full gene sequencing | 6 weeks | 1200 |
| GENE | Hyperparathyroidism - CASR sequencing | 6 weeks | 1200 |
| GENE | Marfan Syndrome - FBN1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Medium-Chain Acyl-CoA Dehydrogenase Deficiency - ACADM sequencing | 5 weeks | 1200 |
| GENE | Nystagmus, X-linked Infantile - FRMD7 gene sequencing | 6 weeks | 1200 |
| GENE | Pelizaeus-Merzbacher Disease - PLP1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Pendred Syndrome - SLC26A4 gene sequencing | 6 weeks | 1200 |
| GENE | Peutz-Jegher Syndrome - STK1 sequencing + deletions/duplications | 5 weeks | 1200 |
| GENE | POLG-Related Disorders - full POLG sequencing + deletions and duplications | 6 weeks | 1200 |
| GENE | Retinoblastoma - RB1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Rett Syndrome (MECP2 gene only) - full sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Short-Chain Acyl-CoA Dehydrogenase Deficiency - ACADS sequencing | 6 weeks | 1200 |
| GENE | Short Stature - SHOX variant screening + deletions/duplications | 8 weeks | 1200 |
| GENE | Smith-Lemli-Opitz Syndrome - DHCR7 sequencing | 5 weeks | 1200 |
| GENE | Sotos Syndrome (Cerebral Gigantism) - NSD1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Very Long-Chain Acyl-CoA Dehydrogenase Deficiency - ACADVl sequencing | 6 weeks | 1200 |
| GENE | Von Hippel-Lindau Syndrome - VHL sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Multiple Endocrine Neoplasia Type 1 - full MEN1 sequencing | 6-7 weeks | 1280 |
| GENE | Breast Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Colorectal Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Hereditary Colorectal Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Lynch Syndrome (HNPCC) NGS Panel | 4 weeks | 1360 |
| GENE | Ovarian Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Prostate Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Brugada Syndrome/Long QT Syndrome NGS Panel | 4-6 weeks | 1760 |
| GENE | Cardiomyopathy, Dilated NGS Panel | 6 weeks | 1760 |
| GENE | Cardiomyopathy, Hypertrophic NGS Panel | 6 weeks | 1760 |
| GENE | Dilated Cardiomyopathy NGS Panel | 6 weeks | 1760 |
| GENE | Endometrial Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Epilepsy, Adolescent/Adult Onset Panel | 6 weeks | 1760 |
| GENE | Kidney/Urinary Tract Comprehensive Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Long QT Syndrome/Brugada Syndrome NGS Panel | 4-6 weeks | 1760 |
| GENE | Melanoma Comprehensive Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Nervous System/Brain Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Pancreatic Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Paraganglioma/Pheochromocytoma NGS Panel | 4 weeks | 1760 |
| GENE | Pheochromocytoma/Paraganglioma NGS Panel | 5 weeks | 1760 |
| GENE | Thyroid Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Urinary Tract/Renal Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Cancer, Comprehensive NGS Panel | 5 weeks | 1920 |
| GENE | Cornelia de Lange Syndrome NGS Panel | 6 weeks | 1920 |
| GENE | Familial Hypocalciuric Hypercalcaemia (FHH) Panel | 6-7 weeks | 1920 |
| GENE | Tuberous Sclerosis (TSC1 + TSC2) | 7 weeks | 1920 |
| GENE | Mitochondrial Genome Sequencing | 6 weeks | 1936 |
| GENE | Neurofibromatosis Type 1 - NF1 + SPRED1 sequencing + deletions/duplications | 8 weeks | 1968 |
| GENE | Facioscapulohumeral Muscular Dystrophy (FSHD) - D4Z4 repeat deletion | 9 weeks | 2000 |
| GENE | Hereditary Comprehensive Cancer NGS Panel | 5 weeks | 2000 |
| GENE | Maturity-Onset Diabetes of the Young (MODY) Diabetes NGS Panel | 12 weeks | 2016 |
| GENE | Amyotrophic Lateral Sclerosis (Motor Neurone Disease) NGS Panel | 5 weeks | 2560 |
| GENE | Angelman/Rett Syndromes NGS Panel | 5 weeks | 2560 |
| GENE | Anophthalmia/Microphthalmia/Coloboma NGS Panel | 6 weeks | 2560 |
| GENE | Ataxia NGS Panel | 6 weeks | 2560 |
| GENE | Autoinflammatory/Periodic Fever NGS Panel | 6 weeks | 2560 |
| GENE | Bardet-Biedl Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Batten Disease (Neuronal Ceroid Lipofuscinosis) NGS Panel | 6 weeks | 2560 |
| GENE | CAKUT (Congenital Anomalies of Kidney & Urinary Tract) NGS Panel | 6 weeks | 2560 |
| GENE | Cardiovascular, Comprehensive NGS Panel | 6 weeks | 2560 |
| GENE | Charcot-Marie-Tooth Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Cholestasis NGS Panel | 6 weeks | 2560 |
| GENE | Congenital Adrenal Hyperplasia NGS Panel | 6 weeks | 2560 |
| GENE | Congenital Myopathy NGS Panel | 6 weeks | 2560 |
| GENE | Connective Tissue Disorders NGS Panel | 6 weeks | 2560 |
| GENE | Craniosynostosis NGS Panel | 6 weeks | 2560 |
| GENE | Diabetes - Obesity NGS Panel | 6 weeks | 2560 |
| GENE | Ehlers-Danlos Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Epidermolysis Bullosa NGS Panel | 6 weeks | 2560 |
| GENE | Epilepsy, Comprehensive NGS Panel | 6 weeks | 2560 |
| GENE | Fatty Acid Oxidation Deficiency NGS Panel | 6 weeks | 2560 |
| GENE | Hearing Loss NGS Panel | 6 weeks | 2560 |
| GENE | Hereditary Spastic Paraplegia Comprehensive NGS Panel | 5 weeks | 2560 |
| GENE | Hirschsprung Disease NGS Panel | 6 weeks | 2560 |
| GENE | Hyperinsulinism NGS Panel | 6 weeks | 2560 |
| GENE | Intellectual Disability NGS Panel | 6 weeks | 2560 |
| GENE | Joubert/Meckel-Gruber Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Kallmann Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Limb-Girdle Muscular Dystrophy (LGMD) NGS Panel | 6 weeks | 2560 |
| GENE | Lissencephaly NGS Panel | 6 weeks | 2560 |
| GENE | Brugada | 6 weeks | 2560 |
| GENE | Marfan Syndrome and Thoracic Aortic Aneurysm and Dissection NGS Panel | 6 weeks | 2560 |
| GENE | Meckel-Gruber/Joubert Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Microphthalmia/Anophthalmia/Coloboma NGS Panel | 6 weeks | 2560 |
| GENE | Motor Neurone Disease (Amyotrophic Lateral Sclerosis) NGS Panel | 5 weeks | 2560 |
| GENE | Mucopolysaccharidosis NGS Panel | 6 weeks | 2560 |
| GENE | Nephrotic Syndrome, Steroid-Resistant NS Panel | 6 weeks | 2560 |
| GENE | Neuronal Ceroid Lipofuscinosis (Batten Disease) NGS Panel | 6 weeks | 2560 |
| GENE | Noonan Syndrome and RASopathies NGS Panel | 6 weeks | 2560 |
| GENE | Osteogenesis Imperfecta NGS Panel | 6 weeks | 2560 |
| GENE | Parkinson-Alzheimer-Dementia NGS Panel | 6 weeks | 2560 |
| GENE | Periodic Fever/Autoinflammation NGS Panel | 6 weeks | 2560 |
| GENE | Polycystic Kidney NGS Panel | 6 weeks | 2560 |
| GENE | Posterior Cerebellar Hypoplasia NGS Panel | 6 weeks | 2560 |
| GENE | Primary Ciliary Dyskinesia (PCD) NGS Panel | 6 weeks | 2560 |
| GENE | Primary Hyperoxaluria NGS Panel | 7 weeks | 2560 |
| GENE | Renal/Urinary Tract Cancer NGS Panel | 4 weeks | 2560 |
| GENE | Rett/Angelman Syndromes NGS Panel | 5 weeks | 2560 |
| GENE | Spastic Paraplegia NGS Panel | 6 weeks | 2560 |
| GENE | Spinocerebellar Ataxia NGS Panel | 6 weeks | 2560 |
| GENE | Treacher Collins Syndrome and Related Disorders NGS Panel | 6 weeks | 2560 |
| GENE | Usher Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Zellweger Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Skeletal Dysplasia NGS Panel | 6 weeks | 3040 |
| GENE | Whole Genome Sequencing (solo/duo/trio) | 5-8 weeks | 5600 |
| GRP | Azoospermia - karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Congenital Absence of Vas Deferens - karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Genetic Reproductive Profile (Male) | 10-15 days | 1076 |
| GRP | Male Genetic Reproductive Profile | 10-15 days | 1076 |
| KARY, FISH | 1p36 Deletion Syndrome – karyotype + CGH | 12-17 days | 974 |
| KARY, FISH | Phelan-McDermid Syndrome - karyotype + FISH | 12-17 days | 974 |
| PBOB | Cri du Chat Syndrome - BOBs only | 5 days | 416 |
| PBOB | Langer-Giedion Syndrome - BOBs only | 5 days | 416 |
| PBOB | Microdeletion (common) Syndromes - BOBs only | 5 days | 416 |
| PBOB | Miller-Dieker Syndrome - BOBs only | 5 days | 416 |
| PBOB | Smith-Magenis Syndrome - BOBs only | 5 days | 416 |
| PBOB | Wolf-Hirschhorn Syndrome - BOBs only | 5 days | 416 |
| PBOB, KARY | Cri du Chat Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Langer-Giedion Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Miller-Dieker Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Smith-Magenis Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Wolf-Hirschhorn Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
You can contact us on 02071832147 to book an appointment for any of the above-listed test.
Join Membership
Call Now
Book Online